Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140066 |
| APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | TABLET | Resolved | 2021-06-11 | 2021-08-03 | 140767 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2021-10-22 | 2021-10-29 | 147806 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2022-09-16 | 2022-10-07 | 169519 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2022-11-11 | 2022-12-05 | 174343 |
| APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | TABLET | Resolved | 2023-02-16 | 2023-04-21 | 185033 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2023-03-09 | 2023-04-21 | 186572 |
| APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | TABLET | Resolved | 2023-05-06 | 2023-06-16 | 191892 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-07 | 2018-01-18 | 28534 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-08-07 | 121322 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-01-20 | 131809 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-23 | 2023-09-01 | 202830 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2023-12-15 | 209372 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-12 | 2024-03-22 | 215973 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-05-10 | 225779 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2019-01-30 | 2019-02-13 | 74014 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-02-13 | 2020-04-23 | 105988 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2020-07-23 | 2021-05-17 | 120971 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122465 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122468 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |